New research strengthens the link between the Shingrix vaccine and a lower risk of dementia. The Shingrix vaccine is designed to lower the risk of shingles. If you received the previous shingles ...

Despite how widespread and devastating it can be, scientists still haven't figured out exactly why some people develop ...

Many are lifestyle changes that you already know you should be making, such as eating healthily, exercising more and keeping ...

In the conclusion of my previous article, I wrote something like, 'Thinking of the drama of the Quillaja tree, I feel like I could endure the pain of the second shingles vaccine side effects with a ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest healthcare news straight to your inbox. Subscribe here to receive future editions. Eli Lilly 's ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the original COVID-19 mRNA vaccine with an immune system enhancer, known as an ...

Shingles is a viral infection caused by the reactivation of the varicella-zoster (aka herpes zoster) virus, the same virus responsible for chickenpox. After you’ve had chickenpox, the virus can stay ...

The large-scale study is one of the first to evaluate the two-dose recombinant zoster vaccine (Shingrix) in a large sample group. Previous research has shown that dementia risk is lower with the ...

In the latest update to COVID and vaccine-related discourse bubbling up at the FDA, agency officials have recently blocked the publication of several safety studies conducted on COVID and shingles ...

The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before release. By Christina Jewett Reporting from Washington Officials at the Food ...

In GSK’s first quarter under Luke Miels as CEO, the company’s flagship shingles vaccine, Shingrix, set a new quarterly sales record, while its closely watched asthma launch, Exdensur, showed “early ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia have demonstrated that an intranasal vaccine booster may confer ...